Your browser doesn't support javascript.
loading
Multilingual markers of depression in remotely collected speech samples: A preliminary analysis.
Cummins, Nicholas; Dineley, Judith; Conde, Pauline; Matcham, Faith; Siddi, Sara; Lamers, Femke; Carr, Ewan; Lavelle, Grace; Leightley, Daniel; White, Katie M; Oetzmann, Carolin; Campbell, Edward L; Simblett, Sara; Bruce, Stuart; Haro, Josep Maria; Penninx, Brenda W J H; Ranjan, Yatharth; Rashid, Zulqarnain; Stewart, Callum; Folarin, Amos A; Bailón, Raquel; Schuller, Björn W; Wykes, Til; Vairavan, Srinivasan; Dobson, Richard J B; Narayan, Vaibhav A; Hotopf, Matthew.
Affiliation
  • Cummins N; Department of Biostatistics and Health Informatics, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, UK. Electronic address: nick.cummins@kcl.ac.uk.
  • Dineley J; Department of Biostatistics and Health Informatics, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, UK; Chair of Embedded Intelligence for Health Care and Wellbeing, University of Augsburg, Germany.
  • Conde P; Department of Biostatistics and Health Informatics, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, UK.
  • Matcham F; School of Psychology, University of Sussex, Falmer, UK; Department of Psychological Medicine, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, UK.
  • Siddi S; Parc Sanitari Sant Joan de Déu, Fundació Sant Joan de Déu, CIBERSAM, Barcelona, Spain.
  • Lamers F; Department of Psychiatry, Amsterdam Public Health Research Institute and Amsterdam Neuroscience, Amsterdam University Medical Centre, Vrije Universiteit and GGZ InGeest, Amsterdam, the Netherlands.
  • Carr E; Department of Biostatistics and Health Informatics, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, UK.
  • Lavelle G; School of Psychology, University of Sussex, Falmer, UK.
  • Leightley D; Department of Psychological Medicine, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, UK.
  • White KM; Department of Psychological Medicine, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, UK.
  • Oetzmann C; Department of Psychological Medicine, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, UK.
  • Campbell EL; Department of Biostatistics and Health Informatics, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, UK; GTM research group, AtlanTTic Research Center, University of Vigo, Spain.
  • Simblett S; Department of Psychology, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, UK.
  • Bruce S; RADAR-CNS Patient Advisory Board, King's College London, UK.
  • Haro JM; Parc Sanitari Sant Joan de Déu, Fundació Sant Joan de Déu, CIBERSAM, Barcelona, Spain.
  • Penninx BWJH; Department of Psychiatry, Amsterdam Public Health Research Institute and Amsterdam Neuroscience, Amsterdam University Medical Centre, Vrije Universiteit and GGZ InGeest, Amsterdam, the Netherlands.
  • Ranjan Y; Department of Biostatistics and Health Informatics, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, UK.
  • Rashid Z; Department of Biostatistics and Health Informatics, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, UK.
  • Stewart C; Department of Biostatistics and Health Informatics, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, UK.
  • Folarin AA; Department of Biostatistics and Health Informatics, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, UK; NIHR Biomedical Research Centre at South London, Maudsley NHS Foundation Trust, King's College London, London, UK.
  • Bailón R; Biomedical Signal Interpretation and Computational Simulation (BSICoS) group, Aragon Institute for Engineering Research, University of Zaragoza, Zaragoza, Spain; Biomedical Research Networking Center in Bioengineering, Biomaterials and Nanomedicine (CIBER-BBN), Spain.
  • Schuller BW; Chair of Embedded Intelligence for Health Care and Wellbeing, University of Augsburg, Germany; GLAM - Group on Language, Audio, & Music, Imperial College London, London, UK.
  • Wykes T; Department of Psychology, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, UK; NIHR Biomedical Research Centre at South London, Maudsley NHS Foundation Trust, King's College London, London, UK.
  • Vairavan S; Janssen Research and Development LLC, Titusville, NJ, United States.
  • Dobson RJB; Department of Biostatistics and Health Informatics, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, UK; Institute of Health Informatics, University College London, London, UK.
  • Narayan VA; Davos Alzheimer's Collaborative, United States.
  • Hotopf M; Department of Psychological Medicine, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, UK; NIHR Biomedical Research Centre at South London, Maudsley NHS Foundation Trust, King's College London, London, UK.
J Affect Disord ; 341: 128-136, 2023 11 15.
Article in En | MEDLINE | ID: mdl-37598722
ABSTRACT

BACKGROUND:

Speech contains neuromuscular, physiological and cognitive components, and so is a potential biomarker of mental disorders. Previous studies indicate that speaking rate and pausing are associated with major depressive disorder (MDD). However, results are inconclusive as many studies are small and underpowered and do not include clinical samples. These studies have also been unilingual and use speech collected in controlled settings. If speech markers are to help understand the onset and progress of MDD, we need to uncover markers that are robust to language and establish the strength of associations in real-world data.

METHODS:

We collected speech data in 585 participants with a history of MDD in the United Kingdom, Spain, and Netherlands as part of the RADAR-MDD study. Participants recorded their speech via smartphones every two weeks for 18 months. Linear mixed models were used to estimate the strength of specific markers of depression from a set of 28 speech features.

RESULTS:

Increased depressive symptoms were associated with speech rate, articulation rate and intensity of speech elicited from a scripted task. These features had consistently stronger effect sizes than pauses.

LIMITATIONS:

Our findings are derived at the cohort level so may have limited impact on identifying intra-individual speech changes associated with changes in symptom severity. The analysis of features averaged over the entire recording may have underestimated the importance of some features.

CONCLUSIONS:

Participants with more severe depressive symptoms spoke more slowly and quietly. Our findings are from a real-world, multilingual, clinical dataset so represent a step-change in the usefulness of speech as a digital phenotype of MDD.
Subject(s)
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Speech / Depressive Disorder, Major Type of study: Diagnostic_studies / Prognostic_studies Limits: Humans Language: En Journal: J Affect Disord Year: 2023 Document type: Article

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Speech / Depressive Disorder, Major Type of study: Diagnostic_studies / Prognostic_studies Limits: Humans Language: En Journal: J Affect Disord Year: 2023 Document type: Article
...